Nurix Therapeutics shares owned by Taddei, Ludwig & Associates
Quarter-by-quarter ownership of Nurix Therapeutics (NRIX) shares owned by Taddei, Ludwig & Associates
from 13F filings
Historical chart of Taddei, Ludwig & Associates investment in Nurix Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Nurix Therapeutics held by Taddei, Ludwig & Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Nurix Therapeutics by Taddei, Ludwig & Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $5.4M | 238k | 22.47 |
| 2024-06-30 | $5.9M | 283k | 20.87 |
| 2024-03-31 | $4.2M | 283k | 14.70 |
| 2023-12-31 | $2.9M | 283k | 10.32 |
| 2023-09-30 | $2.2M | 283k | 7.86 |
| 2023-06-30 | $2.8M | 283k | 9.99 |
| 2023-03-31 | $2.5M | 283k | 8.88 |
| 2022-12-31 | $3.1M | 283k | 10.98 |
| 2022-09-30 | $3.7M | 283k | 13.03 |
| 2022-06-30 | $3.6M | 283k | 12.67 |
| 2022-03-31 | $4.0M | 283k | 14.01 |
| 2021-12-31 | $8.2M | 283k | 28.95 |
| 2021-09-30 | $8.5M | 283k | 29.96 |
| 2021-03-31 | $8.8M | 283k | 31.09 |
More positions owned by Taddei, Ludwig & Associates
View all positions for Taddei, Ludwig & Associates